ÂÜÀòÂÒÂ×

John Donofrio serves as the Company’s Chief Operating Officer and President of EPI Health. He has over 25 years of experience in leading US and International teams in the pharmaceutical industry and brings a proven track record of business, operations, strategic, and financial leadership. Prior to EPI, Mr. Donofrio was CFO at TrialCard, and earlier was CFO and Head of Business Development for Merz North America. In addition to his executive positions, Mr. Donofrio spent over 20 years with GSK in various US and international roles, including Global Vice President of finance for the dermatology business unit, Stiefel, a GSK company. He is also a board member and audit chair for Aytu Bioscience, serves on the board of directors of the Children’s Skin Disease Foundation and Alliance Medical Ministries.

Mr. Donofrio is a graduate of North Carolina State University, with a degree in accounting.